Back to Search
NERSES TCHEKMEDYIAN, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1821032129IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
A42410(CA)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A42410(CA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1978
Research & Publications (19)
The relationship between psychologic distress and cancer-related fatigue.
PMID 12833472·Cancer·2003
3-trial
Anemia in cancer patients: significance, epidemiology, and current therapy.
PMID 12380951·Oncology (Williston Park)·2002
6-review
Utilization of positron emission tomography in the management of patients with sarcoma.
PMID 19412096·Curr Opin Oncol·2009
6-review
Phase II trial of weekly patupilone in patients with castration-resistant prostate cancer.
PMID 19087985·Ann Oncol·2009
3-trial
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro.
PMID 17268817·Breast Cancer Res Treat·2007
8-other
A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer.
PMID 17363537·Clin Cancer Res·2007
3-trial
Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfa.
PMID 17163293·Clin Drug Investig·2006
4-observational
Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.
PMID 16983112·J Clin Oncol·2006
3-trial
Clinical benefit of zoledronic acid in patients with lung cancer and other solid tumors: analysis based on history of skeletal complications.
PMID 15555218·Clin Lung Cancer·2004
3-trial
Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial.
PMID 15197804·Cancer·2004
3-trial
A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
PMID 15073859·Cancer·2004
3-trial
Hemoglobin increase is associated with improved health-related quality of life in patients with cancer not receiving chemotherapy.
PMID 18628131·Support Cancer Ther·2003
8-other
A dose- and schedule-finding study of darbepoetin alpha for the treatment of chronic anaemia of cancer.
PMID 12799626·Br J Cancer·2003
3-trial
Darbepoetin alfa administered every 2 weeks alleviates anemia in cancer patients receiving chemotherapy.
PMID 12435170·Oncology (Williston Park)·2002
3-trial
Psychological outcomes associated with anemia-related fatigue in cancer patients.
PMID 12380961·Oncology (Williston Park)·2002
6-review
Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy.
PMID 12177793·Br J Cancer·2002
3-trial
Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer.
PMID 11308271·Br J Cancer·2001
3-trial
Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.
PMID 11401046·Qual Life Res·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 2100 MAIN ST STE 300
HUNTINGTON BEACH, CA 92648 - Phone
- (714) 252-9415
Quick Facts
- NPI
- 1821032129
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 48
- Publications
- 19
Are you this provider?
Claim Your Profile